Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- TNT With FLOT/Durvalumab Plus Post-OP Durvalumab for Resectable Gastroesophageal AdenocarcinomaNot Yet Recruiting
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Esophagogastric Adenocarcinoma
Germany, Spain
- Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung CancerActive Not Recruiting
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Small Cell Lung Cancer Extensive Stage · Small-cell Lung Cancer
United States
Sponsor: German Heart Institute
Heart Failure With Preserved Ejection Fraction (HFPEF) · Renal Dysfunction · Stage B Heart Failure
Germany
Sponsor: AstraZeneca
Asthma
Taiwan
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Small Lymphocytic Lymphoma (SLL) · Chronic Lymphocytic Leukemia (CLL)
United States
Sponsor: AstraZeneca
Crohn's Disease · IBD
United States, Germany, Poland, South Africa, Taiwan
- Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)Active Not Recruiting
Sponsor: Institut Cancerologie de l'Ouest
Node; Prostate · Bone Metastases · Prostate Cancer Patients
France
Sponsor: AstraZeneca
Pulmonary Disease, Chronic Obstructive (COPD)
Greece
- AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.Active Not Recruiting
Sponsor: AstraZeneca
Stage IB-IIIA Non-small Cell Lung Carcinoma
United States, Australia, Belgium, Brazil, Canada +20 more
- Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene MutationsRecruiting
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Renal Cell Carcinoma · Metastatic Renal Cell Carcinoma · Kidney Cancer · Renal Carcinoma
United States
- Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in ChinaCompleted
Sponsor: AstraZeneca
Lower Respiratory Tract Infection
China
- Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before SurgeryActive Not Recruiting
Sponsor: University of California, San Francisco
Stage I Non-Small Cell Lung Cancer · Stage IA Non-Small Cell Lung Cancer · Stage IB Non-Small Cell Lung Cancer · Stage II Non-Small Cell Lung Cancer
United States
Sponsor: Canadian Cancer Trials Group
Lymphoma, Non-Hodgkin · Multiple Myeloma · Advanced Solid Tumors
Canada
- Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy RegimensActive Not Recruiting
Sponsor: Canadian Cancer Trials Group
Solid Malignancies
Canada
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
NSCLC, Stage III
Germany
Sponsor: AstraZeneca
Acute Decompensated Heart Failure
United Kingdom
- Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary SyndromeRecruiting
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Acute Coronary Syndromes (ACS) · Iron Deficiencies · Elderly (People Aged 65 or More)
Spain
Sponsor: Canadian Cancer Trials Group
Oropharyngeal Squamous Cell Carcinoma
Belgium, Canada, Italy, Spain
Sponsor: Daiichi Sankyo
Non-small Cell Lung Cancer
United States, France, Germany, Hungary, Italy +5 more
- Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform NeurofibromasActive Not Recruiting
Sponsor: AstraZeneca
Neurofibromatosis 1 · Plexiform Neurofibroma (PN)
United States, Australia, Brazil, Canada, China +8 more
- A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating MutationsActive Not Recruiting
Sponsor: AstraZeneca
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
United States, Belgium, Canada, Denmark, France +4 more
Sponsor: Canadian Immunization Research Network
Preventable Disease, Vaccine
Canada
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease
Italy
- EXACOS EG PopulationWithdrawn
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease
Sponsor: AstraZeneca
Advanced Solid Tumours · Non-Small Cell Lung Cancer (NSCLC) · Pancreatic Ductal Adenocarcinoma (PDAC) · Colorectal Cancer (CRC)
United States, Australia, Japan, South Korea